Skip to main content
Erschienen in: Supportive Care in Cancer 11/2019

23.02.2019 | Original Article

Symptom frequency and change of oldest old cancer patients

verfasst von: Linda Pang, Maxine de la Cruz, Jimin Wu, Diane Liu, Mujtaba Naqvi, Eduardo Bruera

Erschienen in: Supportive Care in Cancer | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The oldest old, described as those aged 85 and older, is a growing cancer population. There are limited studies evaluating the symptoms of the oldest old cancer patient population. Our study aimed to evaluate symptom frequency and clinical symptom change as assessed by the Edmonton Symptom Assessment System (ESAS) of the oldest old (≥ 85) compared to older adult (65–84) and general adult (18–64) outpatient cancer patients on initial consult and follow-up visit.

Methods

Retrospective review of a total of 441 patients, 200 randomly sampled patients in the general and older adult group and 41 consecutive patients in the oldest old group. Chart review was performed for demographic and clinical information including ESAS.

Results

The oldest old group had less advanced tumors and worse performance status and was receiving less cancer therapy. Eighty percent or more of these patients reported fatigue, sleep disturbance, appetite, and drowsiness. They experienced lower frequencies of pain (p < 0.0001), fatigue (p = 0.0338), nausea (p = 0.0151), feeling of well-being (p = 0.0245), sleep disturbance (p = 0.0484), financial distress (p = 0.0002), and spiritual distress (p = 0.0010) compared to the younger groups. Twenty-six to fifty-one percent of the oldest old patients’ symptoms improved on the first follow-up visit.

Conclusions

Oldest old cancer patients have high frequencies of multiple symptoms on initial referral. However, these symptom frequencies are lower when compared to younger age groups. Additionally, many of their symptoms improved on first follow-up visit in the palliative care clinic. More research is needed to address the needs of this growing cancer population and focus symptoms that can improve with palliative care intervention.
Literatur
1.
Zurück zum Zitat von Faber M, Bootsma–van der Wiel A, van Exel E, Gussekloo J, Lagaay AM, van Dongen E, Knook DL, van der Geest S, Westendorp RGJ (2001) Successful aging in the oldest old: who can be characterized as successfully aged? Arch Intern Med 161(22):2694–2700CrossRef von Faber M, Bootsma–van der Wiel A, van Exel E, Gussekloo J, Lagaay AM, van Dongen E, Knook DL, van der Geest S, Westendorp RGJ (2001) Successful aging in the oldest old: who can be characterized as successfully aged? Arch Intern Med 161(22):2694–2700CrossRef
3.
Zurück zum Zitat Verweij NM, Schiphorst AHW, Maas HA, Zimmerman DDE, van den Bos F, Pronk A, Borel Rinkes IHM, Hamaker ME (2016) Colorectal cancer resections in the oldest old between 2011 and 2012 in the Netherlands. Ann Surg Oncol 23(6):1875–1882PubMedCrossRef Verweij NM, Schiphorst AHW, Maas HA, Zimmerman DDE, van den Bos F, Pronk A, Borel Rinkes IHM, Hamaker ME (2016) Colorectal cancer resections in the oldest old between 2011 and 2012 in the Netherlands. Ann Surg Oncol 23(6):1875–1882PubMedCrossRef
4.
Zurück zum Zitat Abraham A, Habermann EB, Rothenberger DA, Kwaan M, Weinberg AD, Parsons HM, Gupta P, al-Refaie WB (2013) Adjuvant chemotherapy for stage III colon cancer in the oldest old: results beyond clinical guidelines. Cancer 119(2):395–403PubMedCrossRef Abraham A, Habermann EB, Rothenberger DA, Kwaan M, Weinberg AD, Parsons HM, Gupta P, al-Refaie WB (2013) Adjuvant chemotherapy for stage III colon cancer in the oldest old: results beyond clinical guidelines. Cancer 119(2):395–403PubMedCrossRef
5.
Zurück zum Zitat Sud S, Lai P, Zhang T, Clemons M, Wheatley-Price P (2015) Chemotherapy in the oldest old: the feasibility of delivering cytotoxic therapy to patients 80 years old and older. J Geriatr Oncol 6(5):395–400PubMedCrossRef Sud S, Lai P, Zhang T, Clemons M, Wheatley-Price P (2015) Chemotherapy in the oldest old: the feasibility of delivering cytotoxic therapy to patients 80 years old and older. J Geriatr Oncol 6(5):395–400PubMedCrossRef
6.
Zurück zum Zitat Ritchie C, Dunn LB, Paul SM, Cooper BA, Skerman H, Merriman JD, Aouizerat B, Alexander K, Yates P, Cataldo J, Miaskowski C (2014) Differences in the symptom experience of older oncology outpatients. J Pain Symptom Manag 47(4):697–709CrossRef Ritchie C, Dunn LB, Paul SM, Cooper BA, Skerman H, Merriman JD, Aouizerat B, Alexander K, Yates P, Cataldo J, Miaskowski C (2014) Differences in the symptom experience of older oncology outpatients. J Pain Symptom Manag 47(4):697–709CrossRef
7.
Zurück zum Zitat Van Lancker A et al (2014) Prevalence of symptoms in older cancer patients receiving palliative care: a systematic review and meta-analysis. J Pain Symptom Manag 47(1):90–104CrossRef Van Lancker A et al (2014) Prevalence of symptoms in older cancer patients receiving palliative care: a systematic review and meta-analysis. J Pain Symptom Manag 47(1):90–104CrossRef
8.
Zurück zum Zitat Yan H, Sellick K (2004) Symptoms, psychological distress, social support, and quality of life of Chinese patients newly diagnosed with gastrointestinal cancer. Cancer Nurs 27(5):389-99PubMedCrossRef Yan H, Sellick K (2004) Symptoms, psychological distress, social support, and quality of life of Chinese patients newly diagnosed with gastrointestinal cancer. Cancer Nurs 27(5):389-99PubMedCrossRef
9.
Zurück zum Zitat Vigano A, Bruera E, Suarez-Almazor ME (1998) Age, pain intensity, and opioid dose in patients with advanced cancer. Cancer 83(6):1244–1250PubMedCrossRef Vigano A, Bruera E, Suarez-Almazor ME (1998) Age, pain intensity, and opioid dose in patients with advanced cancer. Cancer 83(6):1244–1250PubMedCrossRef
10.
Zurück zum Zitat Cataldo JK, Paul S, Cooper B, Skerman H, Alexander K, Aouizerat B, Blackman V, Merriman J, Dunn L, Ritchie C, Yates P, Miaskowski C (2013) Differences in the symptom experience of older versus younger oncology outpatients: a cross-sectional study. BMC Cancer 13:6PubMedPubMedCentralCrossRef Cataldo JK, Paul S, Cooper B, Skerman H, Alexander K, Aouizerat B, Blackman V, Merriman J, Dunn L, Ritchie C, Yates P, Miaskowski C (2013) Differences in the symptom experience of older versus younger oncology outpatients: a cross-sectional study. BMC Cancer 13:6PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Steindal SA, Bredal IS, Ranhoff AH, Sørbye LW, Lerdal A (2015) The last three days of life: a comparison of pain management in the young old and the oldest old hospitalised patients using the resident assessment instrument for palliative care. Int J Older People Nursing 10(4):263–272CrossRef Steindal SA, Bredal IS, Ranhoff AH, Sørbye LW, Lerdal A (2015) The last three days of life: a comparison of pain management in the young old and the oldest old hospitalised patients using the resident assessment instrument for palliative care. Int J Older People Nursing 10(4):263–272CrossRef
12.
Zurück zum Zitat Hui D, Bruera E (2017) The Edmonton Symptom Assessment System 25 years later: past, present, and future developments. J Pain Symptom Manag 53(3):630–643CrossRef Hui D, Bruera E (2017) The Edmonton Symptom Assessment System 25 years later: past, present, and future developments. J Pain Symptom Manag 53(3):630–643CrossRef
13.
Zurück zum Zitat Hui D, Shamieh O, Paiva CE, Perez-Cruz PE, Kwon JH, Muckaden MA, Park M, Yennu S, Kang JH, Bruera E (2015) Minimal clinically important differences in the Edmonton Symptom Assessment Scale in cancer patients: a prospective, multicenter study. Cancer 121(17):3027–3035PubMedPubMedCentralCrossRef Hui D, Shamieh O, Paiva CE, Perez-Cruz PE, Kwon JH, Muckaden MA, Park M, Yennu S, Kang JH, Bruera E (2015) Minimal clinically important differences in the Edmonton Symptom Assessment Scale in cancer patients: a prospective, multicenter study. Cancer 121(17):3027–3035PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Mohile SG, Heckler C, Fan L, Mustian K, Jean-Pierre P, Usuki K, Sprod L, Janelsins M, Purnell J, Peppone L, Palesh O, Devine KA, Morrow G (2011) Age-related differences in symptoms and their interference with quality of life in 903 cancer patients undergoing radiation therapy. J Geriatr Oncol 2(4):225–232PubMedPubMedCentralCrossRef Mohile SG, Heckler C, Fan L, Mustian K, Jean-Pierre P, Usuki K, Sprod L, Janelsins M, Purnell J, Peppone L, Palesh O, Devine KA, Morrow G (2011) Age-related differences in symptoms and their interference with quality of life in 903 cancer patients undergoing radiation therapy. J Geriatr Oncol 2(4):225–232PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Cohen L, de Moor CA, Eisenberg P, Ming EE, Hu H (2007) Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings. Support Care Cancer 15(5):497–503PubMedCrossRef Cohen L, de Moor CA, Eisenberg P, Ming EE, Hu H (2007) Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings. Support Care Cancer 15(5):497–503PubMedCrossRef
16.
Zurück zum Zitat Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, Colvin LA, Fallon M (2014) Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain 155(12):2461–2470PubMedCrossRef Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, Colvin LA, Fallon M (2014) Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain 155(12):2461–2470PubMedCrossRef
17.
Zurück zum Zitat Galenkamp H, Huisman M, Braam AW, Deeg DJH (2012) Estimates of prospective change in self-rated health in older people were biased owing to potential recalibration response shift. J Clin Epidemiol 65(9):978–988PubMedCrossRef Galenkamp H, Huisman M, Braam AW, Deeg DJH (2012) Estimates of prospective change in self-rated health in older people were biased owing to potential recalibration response shift. J Clin Epidemiol 65(9):978–988PubMedCrossRef
18.
Zurück zum Zitat Breitbart W, Rosenfeld B, Roth A, Smith MJ, Cohen K, Passik S (1997) The memorial delirium assessment scale. J Pain Symptom Manag 13(3):128–137CrossRef Breitbart W, Rosenfeld B, Roth A, Smith MJ, Cohen K, Passik S (1997) The memorial delirium assessment scale. J Pain Symptom Manag 13(3):128–137CrossRef
20.
Zurück zum Zitat Reilly CM, Bruner DW, Mitchell SA, Minasian LM, Basch E, Dueck AC, Cella D, Reeve BB (2013) A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment. Support Care Cancer 21(6):1525–1550PubMedPubMedCentralCrossRef Reilly CM, Bruner DW, Mitchell SA, Minasian LM, Basch E, Dueck AC, Cella D, Reeve BB (2013) A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment. Support Care Cancer 21(6):1525–1550PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Reuben DB et al. (2018) Geriatrics At Your Fingertips: 2018, 20th Edition. New York: The American Geriatrics Society Reuben DB et al. (2018) Geriatrics At Your Fingertips: 2018, 20th Edition. New York: The American Geriatrics Society
22.
Zurück zum Zitat Shankaran V, Jolly S, Blough D, Ramsey SD (2012) Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. J Clin Oncol 30(14):1608–1614PubMedCrossRef Shankaran V, Jolly S, Blough D, Ramsey SD (2012) Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. J Clin Oncol 30(14):1608–1614PubMedCrossRef
23.
Zurück zum Zitat Ramsey S, Blough D, Kirchhoff A, Kreizenbeck K, Fedorenko C, Snell K, Newcomb P, Hollingworth W, Overstreet K (2013) Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff (Millwood) 32(6):1143–1152CrossRef Ramsey S, Blough D, Kirchhoff A, Kreizenbeck K, Fedorenko C, Snell K, Newcomb P, Hollingworth W, Overstreet K (2013) Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff (Millwood) 32(6):1143–1152CrossRef
24.
Zurück zum Zitat Langa KM, Fendrick AM, Chernew ME, Kabeto MU, Paisley KL, Hayman JA (2004) Out-of-pocket health-care expenditures among older Americans with cancer. Value Health 7(2):186–194PubMedCrossRef Langa KM, Fendrick AM, Chernew ME, Kabeto MU, Paisley KL, Hayman JA (2004) Out-of-pocket health-care expenditures among older Americans with cancer. Value Health 7(2):186–194PubMedCrossRef
25.
Zurück zum Zitat Bock JO, König HH, Brenner H, Haefeli WE, Quinzler R, Matschinger H, Saum KU, Schöttker B, Heider D (2016) Associations of frailty with health care costs--results of the ESTHER cohort study. BMC Health Serv Res 16:128PubMedPubMedCentralCrossRef Bock JO, König HH, Brenner H, Haefeli WE, Quinzler R, Matschinger H, Saum KU, Schöttker B, Heider D (2016) Associations of frailty with health care costs--results of the ESTHER cohort study. BMC Health Serv Res 16:128PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Portz JD, Kutner JS, Blatchford PJ, Ritchie CS (2017) High symptom burden and low functional status in the setting of multimorbidity. J Am Geriatr Soc 65(10):2285–2289PubMedPubMedCentralCrossRef Portz JD, Kutner JS, Blatchford PJ, Ritchie CS (2017) High symptom burden and low functional status in the setting of multimorbidity. J Am Geriatr Soc 65(10):2285–2289PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Smith TJ, Temin S, Alesi ER, Abernethy AP, Balboni TA, Basch EM, Ferrell BR, Loscalzo M, Meier DE, Paice JA, Peppercorn JM, Somerfield M, Stovall E, von Roenn JH (2012) American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 30(8):880–887PubMedCrossRef Smith TJ, Temin S, Alesi ER, Abernethy AP, Balboni TA, Basch EM, Ferrell BR, Loscalzo M, Meier DE, Paice JA, Peppercorn JM, Somerfield M, Stovall E, von Roenn JH (2012) American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 30(8):880–887PubMedCrossRef
28.
Zurück zum Zitat Yennurajalingam S, Urbauer DL, Casper KLB, Reyes-Gibby CC, Chacko R, Poulter V, Bruera E (2011) Impact of a palliative care consultation team on cancer-related symptoms in advanced cancer patients referred to an outpatient supportive care clinic. J Pain Symptom Manag 41(1):49–56CrossRef Yennurajalingam S, Urbauer DL, Casper KLB, Reyes-Gibby CC, Chacko R, Poulter V, Bruera E (2011) Impact of a palliative care consultation team on cancer-related symptoms in advanced cancer patients referred to an outpatient supportive care clinic. J Pain Symptom Manag 41(1):49–56CrossRef
29.
Zurück zum Zitat Sasahara T, Watakabe A, Aruga E, Fujimoto K, Higashi K, Hisahara K, Hori N, Ikenaga M, Izawa T, Kanai Y, Kinoshita H, Kobayakawa M, Kobayashi K, Kohara H, Namba M, Nozaki-Taguchi N, Osaka I, Saito M, Sekine R, Shinjo T, Suga A, Tokuno Y, Yamamoto R, Yomiya K, Morita T (2014) Assessment of reasons for referral and activities of hospital palliative care teams using a standard format: a multicenter 1000 case description. J Pain Symptom Manag 47(3):579–587.e6CrossRef Sasahara T, Watakabe A, Aruga E, Fujimoto K, Higashi K, Hisahara K, Hori N, Ikenaga M, Izawa T, Kanai Y, Kinoshita H, Kobayakawa M, Kobayashi K, Kohara H, Namba M, Nozaki-Taguchi N, Osaka I, Saito M, Sekine R, Shinjo T, Suga A, Tokuno Y, Yamamoto R, Yomiya K, Morita T (2014) Assessment of reasons for referral and activities of hospital palliative care teams using a standard format: a multicenter 1000 case description. J Pain Symptom Manag 47(3):579–587.e6CrossRef
30.
Zurück zum Zitat Braiteh F, el Osta B, Palmer JL, Reddy SK, Bruera E (2007) Characteristics, findings, and outcomes of palliative care inpatient consultations at a comprehensive cancer center. J Palliat Med 10(4):948–955PubMedCrossRef Braiteh F, el Osta B, Palmer JL, Reddy SK, Bruera E (2007) Characteristics, findings, and outcomes of palliative care inpatient consultations at a comprehensive cancer center. J Palliat Med 10(4):948–955PubMedCrossRef
31.
Zurück zum Zitat Kuin A, Courtens AM, Deliens L, Vernooij-Dassen MJFJ, van Zuylen L, van der Linden B, van der Wal G (2004) Palliative care consultation in the Netherlands: a nationwide evaluation study. J Pain Symptom Manag 27(1):53–60CrossRef Kuin A, Courtens AM, Deliens L, Vernooij-Dassen MJFJ, van Zuylen L, van der Linden B, van der Wal G (2004) Palliative care consultation in the Netherlands: a nationwide evaluation study. J Pain Symptom Manag 27(1):53–60CrossRef
Metadaten
Titel
Symptom frequency and change of oldest old cancer patients
verfasst von
Linda Pang
Maxine de la Cruz
Jimin Wu
Diane Liu
Mujtaba Naqvi
Eduardo Bruera
Publikationsdatum
23.02.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 11/2019
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-04702-7

Weitere Artikel der Ausgabe 11/2019

Supportive Care in Cancer 11/2019 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.